Menu
Health experts, health advocates, and individuals concerned with men’s prostate health and prostate cancer recognize September as Prostate Cancer Awareness Month in North America.
We are pleased to inform you that we have appointed a new Accuray Exchange (AEx) Advisory Board, which includes a new President.
The Yonsei Cancer Center’s Department of Radiation Oncology in Seoul, South Korea, has published its recent research findings on the effects of stereotactic (APBI) in the International Journal of Radiation, Oncology, Biology, and Physics.
The 5th Breast Roundtable was hosted by Accuray in collaboration with Chiang Mai University Hospital on July 1st, 2023.
Recommendations on the integration of radiation therapy with targeted treatments for breast cancer consensus meeting was held in Florence on June 16th and 17th.
We are looking forward to meeting you at the upcoming AAPM meeting in Houston, Texas.
Pauline Dupuis recently shared her positive experience using VOLO™ Ultra to optimize treatment plans with TomoTherapy®/Radixact® Systems.
It is that time of the year again – the abstract outcomes for ASTRO 2023 have been received.
Advances in Hypofractionation for Breast and Prostate Cancer: A Symposium with Leading Clinical Experts
© 2024 Accuray Incorporated